THE ECONOMIC AND SOCIAL IMPACT OF MIGRAINE

被引：40
作者：
STEWART, WF
LIPTON, RB
机构：
[1] JOHNS HOPKINS UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21205
[2] MONTEFIORE MED CTR,ALBERT EINSTEIN COLL MED,DEPT NEUROL,HEADACHE UNIT,NEW YORK,NY 10467
[3] MONTEFIORE MED CTR,ALBERT EINSTEIN COLL MED,DEPT EPIDEMIOL & SOCIAL MED,NEW YORK,NY 10467
来源：
EUROPEAN NEUROLOGY | 1994年 / 34卷
关键词：
MIGRAINE; SOCIOECONOMICS; DISABILITY; PAIN INTENSITY;
D O I：
10.1159/000119527
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Migraine is an episodic disorder which is often disabling both during and between attacks. While pain intensity is the most important symptom to individual sufferers, headache-related disability is the major determinant of the economic impact of illness. Because migraine is underdiagnosed and undertreated, cost-effective healthcare interventions could serve to reduce the burden of illness on individual sufferers and society. Measures which assess both pain intensity and disability might serve to capture the essential elements of migraine and provide the basis for effective healthcare interventions.
引用
收藏
页码：12 / 17
页数：6
相关论文
共 50 条
[21]   Migraine-related Disabilities Among Saudi Migraine Patients and its Association with Social Factors [J].
AboTaleb, Hanin Abdulbaset ;
Al-Hayani, Majed Mohammad ;
Alghamdi, Badrah Saeed .
ARCHIVES OF NEUROSCIENCE, 2021, 8 (01)
[22]   The Economic Cost of Patients With Migraine Headache Referred to Specialist Clinics [J].
Osumili, Beatrice ;
McCrone, Paul ;
Cousins, Sian ;
Ridsdale, Leone .
HEADACHE, 2018, 58 (02) :287-294
[23]   Economic burden of migraine in Latvia and Lithuania: direct and indirect costs [J].
Lubloy, Agnes .
BMC PUBLIC HEALTH, 2019, 19 (01)
[24]   Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway [J].
Hansson-Hedblom, Amanda ;
Axelsson, Isabelle ;
Jacobson, Lena ;
Tedroff, Joakim ;
Borgstrom, Fredrik .
JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01)
[25]   The impact of pharmacogenetics for migraine [J].
Ophoff, RA ;
van den Maagdenberg, AMJM ;
Roon, KI ;
Ferrari, MD ;
Frants, RR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 413 (01) :1-10
[26]   The epidemiology and impact of migraine [J].
Bigal M.E. ;
Lipton R.B. ;
Stewart W.F. .
Current Neurology and Neuroscience Reports, 2004, 4 (2) :98-104
[27]   Impact of migraine on the family [J].
Smith, R .
HEADACHE, 1998, 38 (06) :423-426
[28]   Economic Impact of Migraine and Other Episodic Headaches in FranceData from the GRIM2000 Study [J].
André Pradalier ;
Jean-Paul Auray ;
Abdelkader El Hasnaoui ;
Kazem Alzahouri ;
Jean-François Dartigues ;
Gérard Duru ;
Patrick Henry ;
Michel Lantéri-Minet ;
Christian Lucas ;
Guy Chazot ;
Anne-François Gaudin .
PharmacoEconomics, 2004, 22 :985-999
[29]   The impact of the COVID-19 pandemic on patients with migraine [J].
Hrytsenko, Olena ;
Kopchak, Oksana ;
Kozyk, Marko ;
Strubchevska, Kateryna .
SAGE OPEN MEDICINE, 2023, 11
[30]   The role of psychological flexibility in migraine headache impact and depression [J].
Almarzooqi, Sarah ;
Chilcot, Joseph ;
McCracken, Lance M. .
JOURNAL OF CONTEXTUAL BEHAVIORAL SCIENCE, 2017, 6 (02) :239-243
12345